Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1975 of 2026 entries
View as:

A Study of RO4995819 in Combination With Citalopram in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01367756 Org: User:
Start: 05/31/11 End: 09/30/11 Due: 09/30/12

Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03386721 Org: User:
Start: 02/19/18 End: 12/30/21 Due: 12/30/22

A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)

Phase: N/A Priority: Normal
NCT ID: NCT00773513 Org: User:
Start: 12/12/08 End: 07/27/17 Due: 07/27/18

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)

Phase: N/A Priority: Normal
NCT ID: NCT01643863 Org: User:
Start: 08/31/12 End: 08/31/12 Due: 08/31/13

Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

Phase: N/A Priority: Normal
NCT ID: NCT00087607 Org: User:
Start: 01/31/04 End: 04/30/06 Due: 04/30/07

Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)

Phase: N/A Priority: Normal
NCT ID: NCT03943550 Org: User:
Start: 05/13/19 End: 07/22/21 Due: 07/22/22

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT06774859 Org: User:
Start: 10/27/24 End: 05/08/25 Due: 05/08/26

Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UK

Phase: N/A Priority: Normal
NCT ID: NCT02658747 Org: User:
Start: 05/25/16 End: 07/25/16 Due: 07/25/17

A Study of Two-Weekly Intravenous Mircera for the Treatment of Dialysis Patients With Chronic Renal Anemia Not Receiving ESA Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT00737711 Org: User:
Start: 07/31/08 End: 10/31/09 Due: 10/31/10

A Study for Monthly Methoxy Polyethylene Glycol-Epoetin Beta Treatment in Patients With Chronic Renal Anaemia

Phase: N/A Priority: Normal
NCT ID: NCT01066000 Org: User:
Start: 10/31/09 End: 09/30/11 Due: 09/30/12

A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System

Phase: N/A Priority: Normal
NCT ID: NCT05275010 Org: User:
Start: 05/30/22 End: 10/03/23 Due: 10/03/24

Vamikibart in Participants With Uveitic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT05642325 Org: User:
Start: 03/23/23 End: 12/14/25 Due: 12/14/26

Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin

Phase: N/A Priority: Normal
NCT ID: NCT02508090 Org: User:
Start: 08/02/13 End: 01/13/17 Due: 01/13/18

A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01251120 Org: User:
Start: 11/30/11 End: 01/31/13 Due: 01/31/14

Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection

Phase: N/A Priority: Normal
NCT ID: NCT02733419 Org: User:
Start: 12/31/04 End: 03/31/08 Due: 03/31/09

A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00077857 Org: User:
Start: 07/31/03 End: 03/31/10 Due: 03/31/11

A Study of RO4989991 in Patients With Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01152619 Org: User:
Start: 07/31/10 End: 02/28/11 Due: 02/28/12

An Observational Study of Valcyte (Valganciclovir) in D+/R- Liver Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT02062294 Org: User:
Start: 07/31/10 End: 09/30/11 Due: 09/30/12

Clinical Impact and Utility of Digital Health Solutions in Participants Receiving Systemic Treatment in Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT05694013 Org: User:
Start: 02/27/23 End: 07/04/24 Due: 07/04/25

A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT02320435 Org: User:
Start: 02/02/15 End: 05/31/26 Due: 05/31/27

A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors with Resectable Disease with Intermediate-High Risk of Recurrence and High Tumor Mutational Burden (TMB-H) or Microsatellite Instability (MSI-H)

Phase: N/A Priority: Normal
NCT ID: NCT06331598 Org: User:
Start: 11/30/24 End: 09/20/29 Due: 09/20/30

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibition

Phase: N/A Priority: Normal
NCT ID: NCT04654468 Org: User:
Start: 03/17/21 End: 12/31/26 Due: 12/31/27

Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00087581 Org: User:
Start: 06/30/04 End: 09/30/07 Due: 09/30/08

The Pharmacokinetics and Safety of Onartuzumab (MetMAb) in Chinese Patients With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02031731 Org: User:
Start: 01/13/14 End: 04/14/14 Due: 04/14/15

A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00439426 Org: User:
Start: 04/30/07 End: 09/30/09 Due: 09/30/10